Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PTI

Proteostasis Therapeutics (PTI) Stock Price, News & Analysis

Proteostasis Therapeutics logo

About Proteostasis Therapeutics Stock (NASDAQ:PTI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.00
$22.42
52-Week Range
N/A
Volume
9,405 shs
Average Volume
1.04 million shs
Market Capitalization
$37.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Proteostasis Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

PTI Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
See More Headlines

PTI Stock Analysis - Frequently Asked Questions

Proteostasis Therapeutics, Inc. (NASDAQ:PTI) posted its quarterly earnings data on Monday, November, 16th. The company reported ($0.16) earnings per share for the quarter, topping analysts' consensus estimates of ($0.17) by $0.01.

Proteostasis Therapeutics (PTI) raised $51 million in an IPO on Thursday, February 11th 2016. The company issued 3,900,000 shares at a price of $12.00-$14.00 per share. Leerink Partners and RBC Capital Markets acted as the underwriters for the IPO and Baird and H.C. Wainwright & Co. were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Proteostasis Therapeutics investors own include BHP Group (BHP), Idera Pharmaceuticals (IDRA), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Bristol Myers Squibb (BMY), Rite Aid (RAD) and

Company Calendar

Last Earnings
11/16/2020
Today
7/13/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PTI
CIK
1445283
Fax
N/A
Employees
44
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.16)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$59.13 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-75.39%
Return on Assets
-55.04%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.69
Quick Ratio
6.69

Sales & Book Value

Annual Sales
$5 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.22 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
52,185,000
Free Float
N/A
Market Cap
$37.57 million
Optionable
Not Optionable
Beta
1.16
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:PTI) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners